GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Gross Profit

Aadi Bioscience (FRA:3350) Gross Profit : €19.33 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Gross Profit?

Aadi Bioscience's gross profit for the three months ended in Mar. 2024 was €4.33 Mil. Aadi Bioscience's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was €19.33 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Aadi Bioscience's gross profit for the three months ended in Mar. 2024 was €4.33 Mil. Aadi Bioscience's Revenue for the three months ended in Mar. 2024 was €4.93 Mil. Therefore, Aadi Bioscience's Gross Margin % for the quarter that ended in Mar. 2024 was 87.82%.

Aadi Bioscience had a gross margin of 87.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 4 years, the highest Gross Margin % of Aadi Bioscience was 91.23%. The lowest was 87.70%. And the median was 89.85%.


Aadi Bioscience Gross Profit Historical Data

The historical data trend for Aadi Bioscience's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Gross Profit Chart

Aadi Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
11.51 0.89 13.10 19.76

Aadi Bioscience Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.99 5.12 4.93 4.95 4.33

Competitive Comparison of Aadi Bioscience's Gross Profit

For the Biotechnology subindustry, Aadi Bioscience's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aadi Bioscience's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's Gross Profit distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's Gross Profit falls into.



Aadi Bioscience Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Aadi Bioscience's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=22.333 - 2.576
=19.76

Aadi Bioscience's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=4.925 - 0.6
=4.33

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €19.33 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Aadi Bioscience's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=4.33 / 4.925
=87.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Aadi Bioscience  (FRA:3350) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aadi Bioscience had a gross margin of 87.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Aadi Bioscience Gross Profit Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Aadi Bioscience (FRA:3350) Business Description

Traded in Other Exchanges
Address
17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines